William Richard White sold $428k of IRON
director at Disc Medicine, Inc.. 7,337 shares at an average of $58.27, traded Nov 1, 2024, filed Nov 5, 2024.
Score components
- +15RoleDirector
- +17Trade size$428k at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.8%, 3m -16.1%, 6m -34.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-121732, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | MOption exercise Common Stock10b5-1 | +201 | $9.86 | $1,982 | 201 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -72 | $45.68 | $3,289 | 129 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -129 | $46.75 | $6,030 | 0 | Nov 5, 2024 |
| Nov 4, 2024 | MOption exercise Common Stock10b5-1 | +7,136 | $45.69 | $326k | 7,136 | Nov 5, 2024 |
| Nov 4, 2024 | SOpen-market sale Common Stock10b5-1 | -1,790 | $57.59 | $103k | 5,346 | Nov 5, 2024 |
| Nov 4, 2024 | SOpen-market sale Common Stock10b5-1 | -5,346 | $58.94 | $315k | 0 | Nov 5, 2024 |
| Nov 1, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -201 | $0.00 | $0 | 2,005 | Nov 5, 2024 |
| Nov 4, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,136 | $0.00 | $0 | 0 | Nov 5, 2024 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 42Moderate | IRONsell Disc Medicine, Inc. | Ai Dmi LLC owner | $60M 744,047 shares | -21% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $140k 2,287 shares | -0% | |
| 20Weak | Disc Medicine, Inc. | Kevin Bitterman director | $2.0M 32,174 shares | -5% | |
| 0Weak | Disc Medicine, Inc. | Kevin Bitterman director | $24k 395 shares | -0% | |
| 21Weak | Disc Medicine, Inc. | Kevin Bitterman director | $518k 8,492 shares | -1% | |
| 55Moderate | Disc Medicine, Inc. | Kevin Bitterman director | $2.6M 42,870 shares | -6% | |
| 36Weak | Disc Medicine, Inc. | Kevin Bitterman director | $41k 664 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.